← Leaderboards
Rajeev Dhupar
Veterans Health Administration
$0
Attributed
$0
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2021–25$1$1$1$0$0
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 2
IK2$0 · 1
Top collaborators
- Adam Christopher Soloff2 shared
- Rudolph C Johnson1 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Saurabh Chatterjee$2,735,380
- John Osterholzer$0
- Anna Woodbury$0
- Jennifer A Gaddy$1,682,172
- Lawrence P Reagan$1,413,365
Others in their field
Other Emerging Leaders on “Veterans”
- John Damon Chodera · Sloan-Kettering Inst Can Research$25,066,508
- Bradley G Hammill · Duke University$15,773,864
- Virginia Kan · George Washington University$13,363,264
- John Freymann · Leidos Biomedical Research, Inc.$8,749,308
- Bradley George Phillips · Emory University$7,008,211
- Joyce Ho · Northwestern University$6,286,883
Research focus
VeteransImmuneResponseRespiratoryPathway InteractionsCellsMalignant NeoplasmsInsightCancer EtiologyAdoptive TransferPharmaceutical PreparationsMalignant Neoplasm Of LungPre-ClinicalClinical TrialsAutologousCellular Metabolic ProcessCessation Of LifeCell PhysiologyDrainage ProcedureEffectivenessCancer CellCytokineCancer PatientClinical Application
Grant awards (6)
The Role of Macrophages in Deployment-related Lung Disease in OEF/OIF/OND Veterans$0
I01 · FY2025 · VA
Lung Cancer Susceptibility in Deployed Gulf War Veterans$0
I01 · FY2024 · VA
Novel Use of Malignant Pleural Effusion Resident T cells for Systemic Adoptive Cell Transfer in Veterans with Lung Cancer$0
IK2 · FY2024 · VA · contact PI
Novel Use of Malignant Pleural Effusion Resident T cells for Systemic Adoptive Cell Transfer in Veterans with Lung Cancer$0
IK2 · FY2023 · VA · contact PI
Novel Use of Malignant Pleural Effusion Resident T cells for Systemic Adoptive Cell Transfer in Veterans with Lung Cancer$0
IK2 · FY2022 · VA · contact PI
Novel Use of Malignant Pleural Effusion Resident T cells for Systemic Adoptive Cell Transfer in Veterans with Lung Cancer$0
IK2 · FY2021 · VA · contact PI